An air traffic controller for more than 30 years, Eric Tandberg is used to living…
sciencecityMarch 31, 2023
Explore Now
News and Articles
Sonoma Biotherapeutics is partnering with Regeneron to co-develop cell therapies for Crohn’s disease and other autoimmune…
sciencecityMarch 30, 2023
Tiara Schwarze-Taufiq traces her love of science to a young age. She recalls browsing educational…
sciencecityMarch 30, 2023
THE BREAD MACHINE Anne McCloskey bought sits idle in her Magnolia home. So do her new…
sciencecityMarch 30, 2023
New funding: Notch Therapeutics has raised a $85 million Series A round, bringing its total funding to…
kchenFebruary 22, 2021
Seagen Inc. (Nasdaq:SGEN) and Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D.,…
emcguinnFebruary 18, 2021
In the race for a COVID-19 vaccine, messenger RNA (mRNA) vaccines finished first. This includes…
emcguinnFebruary 17, 2021
Seagen Inc. (Nasdaq:SGEN) today announced that the European Commission (EC) has granted marketing authorization for…
emcguinnFebruary 17, 2021
News and Articles
Advances in the functional genomics and bioinformatics toolkits for Strongyloides species have positioned these species as genetically…
karnottDecember 8, 2023
Phase Genomics, Inc., a global innovator for industry-leading genomic solutions, today announced the presentation of…
karnottDecember 8, 2023
The Allen Institute, the Chan Zuckerberg Initiative and the University of Washington have launched a…
karnottDecember 8, 2023
Upcoming Events in Seattle
Stay up-to-date with all of the life science events taking place in Seattle with the Science in Seattle events calendar!
